PIRS   $13.26  -17.69% Market Closed

Pieris Pharmaceuticals Inc
Total Cash 19.73M
totalCashPerShare 14.945
EBITDA -11.34M
Total Debt 0.00
quickRatio 3.845
currentRatio 3.948
Total Revenue 20.87M
debtToEquity
Revenue/Share 16.66
ROA -0.13184
ROE -0.80461997
grossProfits
freeCashflow -25.49M
operatingCashflow -37.87M
earningsGrowth
revenueGrowth
grossMargins 0.23256001
ebitdaMargins -0.54307
operatingMargins -0.56899
profitMargins -1.14115
enterpriseValue 2.71M
forwardPE
floatShares 808.12K
sharesOutstanding 1.32M
sharesShort 26.82K
sharesShortPriorMonth 36.44K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.50%
Short Ratio help_outline 3.63%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 14.168
Price To Book help_outline 1.18
earningsQuarterlyGrowth
netIncomeToCommon -23.82M
trailingEps -19.21%
forwardEps -0.20%
enterpriseToEbitda -0.24
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2023
institutionsCount 27
lastUpdated Nov. 6, 2024, 6:30 p.m.